ELIXINOL WELLNESS ORD
Elixinol Global strikes exclusive multimillion-dollar deal with Pet Releaf
Cannabis company Elixinol Global (ASX: EXL) has unveiled a new manufacturing and supply agreement with Altmed Pets, otherwise known as Pet Releaf, in a deal that has the potential to add significant value to its balance sheet in the near term. The deal is worth US$18 million (A$26.8 million) over the next 18 months with a […]
Elixinol Global marks first cannabidiol shipment to New Zealand following law change
Elixinol Global’s (ASX: EXL) cannabidiol (CBD) products have now been made available on a prescription basis in New Zealand following a recent softening in legislation on medical cannabis. With prescriptions already flowing in via its e-commerce website, the company has also declared its maiden CBD shipment to the country. It comes after the passage of […]
Elixinol Global doubles in size since ASX debut, reports maiden profit
Cannabis stock Elixinol Global (ASX: EXL) has more than doubled its revenue and delivered a maiden profit in the first six months since listing on the Australian Securities Exchange. The company, which operates in the industrial hemp, dietary supplements and emerging medicinal cannabis sectors, today released its financial results for the first half of 2018, […]
US Senate gives the green light for industrial hemp legalisation
The sweeping reforms that have facilitated the reintroduction of medicinal cannabis into North America have spilt over into helping its natural sibling: industrial hemp. The US has just past reforms that could help reinstate industrial hemp’s once-proud status as one of the most ubiquitously useful resources in society. The wide-ranging agriculture and food policy legislation […]